Profil
Ming Hao Sun is Senior Vice President-Quality Control & Research at Capricor Therapeutics, Inc. since 2021.
Former roles include Director-Stem Cell Research at Trans Ova Genetics LC from 2019 to 2020 and General Manager-San Diego Site at Precigen, Inc. from 2012 to 2019.
Education includes a doctorate from The Pennsylvania State University and undergraduate and graduate degrees from Wuhan University.
Aktive Positionen von Ming Hao Sun
| Unternehmen | Position | Beginn |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Ming Hao Sun
| Unternehmen | Position | Ende |
|---|---|---|
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Corporate Officer/Principal | 01.05.2020 |
| PRECIGEN, INC. | Corporate Officer/Principal | 01.08.2019 |
Ausbildung von Ming Hao Sun
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Precigen, Inc.
Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
Trans Ova Genetics LC
Trans Ova Genetics LC Medical SpecialtiesHealth Technology Develops embryo transfer technologies to vitro fertilization for animals | Health Technology |
















